2025 |
Sun Pharmaceutical Industries Ltd.
|
Non Executive & Independent Director |
98 L |
25.6 % |
2025 |
Piramal Enterprises Ltd.
|
Independent Director |
52.5 L |
81.0 % |
2024 |
Sun Pharmaceutical Industries Ltd.
|
Non Executive & Independent Director |
78 L |
2.6 % |
2024 |
Piramal Enterprises Ltd.
|
Independent Director |
29 L |
18.4 % |
2024 |
Suzlon Energy Ltd.
|
Independent Non Exe. Director |
7.5 L |
97.4 % |
2023 |
Sun Pharmaceutical Industries Ltd.
|
Non Executive & Independent Director |
76 L |
8.6 % |
2023 |
Piramal Enterprises Ltd.
|
Independent Director |
24.5 L |
- |
2023 |
Suzlon Energy Ltd.
|
Independent Non Exe. Director |
3.8 L |
-44.1 % |
2022 |
Sun Pharmaceutical Industries Ltd.
|
Non Executive & Independent Director |
70 L |
204.3 % |
2022 |
Suzlon Energy Ltd.
|
Non Executive & Independent Director |
6.8 L |
36.0 % |
2021 |
Sun Pharmaceutical Industries Ltd.
|
Non Executive & Independent Director |
23 L |
9.5 % |
2021 |
Suzlon Energy Ltd.
|
Non Executive & Independent Director |
5 L |
- |
2020 |
Sun Pharmaceutical Industries Ltd.
|
Non Executive & Independent Director |
21 L |
61.5 % |
2020 |
Suzlon Energy Ltd.
|
Additional Director |
- |
- |
2019 |
Sun Pharmaceutical Industries Ltd.
|
Independent Director |
13 L |
- |
2019 |
Suzlon Energy Ltd.
|
Additional Director |
- |
- |
2018 |
Sun Pharmaceutical Industries Ltd.
|
Additional Independent Director |
- |
- |
2017 |
Reliance Home Finance Ltd.
|
Director |
6 L |
- |
2017 |
Sun Pharmaceutical Industries Ltd.
|
Additional Independent Director |
- |
- |